Lenrispodun

CAS No.	1160521-50-5	Cat. No.	BCP16186
Name	Lenrispodun
Synonyms	ITI-214; ITI 214; ITI214; PDE1-IN-1;PDE4 (R)-(-)-Rolipram;
Formula	C29H26FN7O	M. Wt	507.56

Description	ITI-214 is an orally active, potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. ITI-214 exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families, and showed good efficacy in vivo. Currently, this investigational new drug is in Phase I clinical development and being considered for the treatment of several indications including cognitive deficits associated with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other CNS and non-CNS disorders.
Related Products	1642303-38-5（Lenrispodun phosphate）
Pathways	Protease/Metabolic Enzyme
Targets	Phosphodiesterase/PDE

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.